HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spanish Firm’s Immunity-Boosting Probiotic Strains Approved For Use In Brazil

Ireland's Kerry Will Market Bio-Cat's Opti-Biome MB40 Probiotic, Develop Branding

Executive Summary

More than 446,000 people in Brazil have died from COVID-19, the second-highest total in the world after the US. Bioresearch Life’s probiotic strains shown to boost the immune system, a health benefit in demand as consumers try to remain coronavirus-free.

You may also be interested in...



USANA Active Nutrition Launch Emphasizes ‘Healthy Body’ For Immune System Support

USANA Health Sciences’ Active Nutrition range, one of its biggest launches, places the focus of health and wellbeing on the gut microbiome for overall healthy body, rather than centering on weight loss.

Wellbeing And Science Trends Will Drive Prebiotic And Probiotic Growth In 2021

Shifts in consumer health behavior towards prevention and science-based products will boost a global probiotics market that is already worth $40bn and is growing by 7% every year, says OptiBiotix CEO Stephen O'Hara. 

Kerry Group Adds Ganeden As Tool For Expanding Probiotic Market

The Irish firm will expand applications for Ganeden’s probiotic innovations, which also will complement Kerry’s Wellmune immune-boosting ingredient. Ganeden is the latest addition to Kerry's businesses targeting North American sales growth.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151408

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel